Dried blood spot microsampling: A semi-quantitative 4D-lipidomics approach using ultrahigh-performance liquid chromatography - high-resolution mass spectrometry (UHPLC - HRMS)
Dried blood spot (DBS) sample collections can offer a minimally invasive, cost-effective alternative to traditional venepuncture for remote sampling and high-frequency metabolic profiling. We present an optimized protocol for DBS-based extraction and comprehensive untargeted 4D lipid profiling using ultrahigh-performance liquid chromatography coupled with high-resolution mass spectrometry (trapped ion mobility - mass spectrometry), designed to support large-scale applications in population-wide lipidomics research. Inclusion of stable isotopically labelled internal standards allowed for semi-quantitative subclass-level correction for 10 μL DBS samples, enhancing the number of reproducible lipids within our curated target list (focussed on 432 unique rule-based lipid annotations out of 6845 features) across positive and negative heated electrospray ionization modes. The reproducibility of unique lipid features detected in replicate DBS (n = 6) was assessed on both peak areas (351 lipids <25 % CV) and calculated concentrations relative to internal standards (432 lipids <25 % CV), underscoring the benefit of internal standard addition. Storage conditions for DBS were also evaluated to determine short-term lipid stability at different temperatures (-20 °C, 4 °C, room temperature, and 45 °C). The majority of lipid subclasses, excluding a minority of glycerophospholipids and oxylipins, were stable up to 1 week at -20 °C and 4 °C (log<sub>2</sub>-fold change <30 % difference), which supports the short-term storage capacity for DBS in field and clinical settings. Similar stability was observed within a week at room temperature, excluding phosphatidylethanolamines and phosphatidylglycerols (log<sub>2</sub>-fold change >30 % difference). Application of the optimized workflow to a microsampling device (n = 6) identified 432 unique lipid features (CV < 25 %) with three repeated samplings over an hour showing minimal impact on lipid profiles by principal component analysis, showing promise for high-frequency, longitudinal DBS monitoring in population health. This work represents a significant advance, highlighting the potential for reliable lipid analysis from DBS samples with short-term stability under various storage conditions, an important logistical benefit for remote or resource-limited settings.
Authors
- Melvin Gay (ORCID: https://orcid.org/0000-0003-2581-4556)
- Jeremy K. Nicholson (ORCID: https://orcid.org/0000-0002-8123-8349)
- Luke Whiley (ORCID: https://orcid.org/0000-0002-9088-4799)
- Julien Wist (ORCID: https://orcid.org/0000-0002-3416-2572)
- Elaine Holmes (ORCID: https://orcid.org/0000-0002-0556-8389)
- Nicola Gray (ORCID: https://orcid.org/0000-0002-0094-5245)
- Nathan G. Lawler (ORCID: https://orcid.org/0000-0001-9649-425X)
- Jayden Lee Roberts (ORCID: https://orcid.org/0000-0003-2236-2945)
- Monique Ryan (ORCID: https://orcid.org/0000-0001-9188-7097)
- Vimalnath Nambiar (ORCID: https://orcid.org/0000-0001-5384-6788)
Institutions
- Murdoch University (AU)
- Bruker (United States) (US)
Publication Details
- Journal
- Talanta
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.talanta.2025.127677
- Citations
- 4
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.19